LB Pharmaceuticals Inc Common Stock
- LBRX
- NASDAQ
- Biotechnology
- Neuropsychiatric Drug Development
- Schizophrenia/Bipolar Depression
$36.74
Today +0.14%Quote Oct 16, 2026, 08:00 PM UTC
−12.81%over the last month
Max drawdown −20.9%From 1-month high −14.5%3 months +18.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.19B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$59.78
+62.7% from here
Floor
$36.28
1.2% below price
Where the price sits
4 analysts
Analyst range, low to high
$35.00$80.00
- Price $36.74
- Resistance $39.44
- Consensus $59.78
The price is just above its floor. Analysts' average target sits about 63% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LBRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
49